37 CFR 1.839 — Incorporation by reference
Ninth Edition, Revision 01.2024
- (a) Certain material is incorporated by reference into this subpart with the approval of the Director of the Federal Register under 5 U.S.C. 552(a) and 1 CFR part 51. All approved incorporation by reference (IBR) material is available for inspection at the USPTO and at the National Archives and Records Administration (NARA). Contact the USPTO’s Office of Patent Legal Administration at 571–272–7701. For information on the availability of this material at NARA, email fr.inspection@ nara.gov or go to www.archives.gov/ federal-register/cfr/ibr-locations.html . The material may be obtained from the source(s) in paragraph (b) of this section.
- (b) World Intellectual Property
Organization (WIPO), 34 chemin des Colombettes, 1211 Geneva 20
Switzerland,
www.wipo.int
.
- (1) WIPO Standard ST.26. WIPO Handbook on Intellectual Property Information and Documentation, Standard ST.26: Recommended Standard for the Presentation of Nucleotide and Amino Acid Sequence Listings Using XML (eXtensible Markup Language) including Annexes I–VII, version 1.6, approved November 25, 2022; IBR approved for §§ 1.831 through 1.834 .
- (2) [Reserved]
[Added 87 FR 30806, May, 20, 2022, effective July 1, 2022; para. (b)(1) revised, 88 FR 34089, May 26, 2023, effective July 1, 2023]
Cited authority
- 37 CFR 1.831 Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures
- 37 CFR 1.834 Form and format for nucleotide and/ or amino acid sequence submissions as the ‘‘Sequence Listing XML’’ in patent applications filed on or after July 1, 2022
Cited by
- 1410 Content of Reissue Application
- 2412 The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures to Include a Sequence Listing in XML file format
- 2412.02(a) “Enumeration of its residues”
- 2412.05(a) Use of Sequentially Numbered Sequence Identifiers in the “Sequence Listing XML”
- 2413.01 Parts of the “Sequence Listing XML”
- 2413.01(a) The “Sequence Listing XML” is a Single File Encoded Using Unicode UTF-8
- 2413.02 Form and Format of the XML file containing the “Sequence Listing XML”
- 2417 Helpful Hints for Sequence Rules Compliance under WIPO Standard ST.26
- 608.05 “Sequence Listing,” “Large Tables,” or “Computer Program Listing Appendix” Submitted in ASCII Plain Text or a “Sequence Listing XML” Submitted as XML File Text
- 37 CFR 1.831 Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures
- 37 CFR 1.832 Representation of nucleotide and/or amino acid sequence data in the “Sequence Listing XML” part of a patent application filed on or after July 1, 2022
- 37 CFR 1.833 Requirements for a “Sequence Listing XML” for nucleotide and/or amino acid sequences as part of a patent application filed on or after July 1, 2022
- 37 CFR 1.834 Form and format for nucleotide and/ or amino acid sequence submissions as the ‘‘Sequence Listing XML’’ in patent applications filed on or after July 1, 2022